ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Mortality"

  • 2019 American Transplant Congress

    Near-Miss Events during Donor Left Liver Lobe Hepatectomy: A Potential Quality-Control to Assess Donor Safety in Living Donor Liver Transplantation Programs

    E. BONACCORSI-RIANI, V. Daudré-Vignier, O. Ciccarelli, L. Coubeau, S. Iesari, R. Tambucci, C. De Magnee, A. Pire, R. Reding

    Cliniques universitaires Saint Luc - Université Catholique de Louvain, Brussels, Belgium

    *Purpose: Living donor liver transplantation (LDLT) is a well-established alternative to alleviate postmortem organ shortage in pediatric liver transplantation. Such program, however, should be performed…
  • 2019 American Transplant Congress

    Cardiovascular Mortality in Transplant Patients; A Population-Based Cohort Study 1988-2013 in Australia and New Zealand

    M. Wyld1, N. De La Mata2, P. Masson3, E. O'Lone2, A. Webster2

    1Renal Department, Royal Prince Alfred Hospital, Camperdown, Australia, 2School of Public Health, University of Sydney, Sydney, Australia, 3Renal Department, Royal Free London NHS Foundation Trust, London, United Kingdom

    *Purpose: Transplant recipients experience excess cardiovascular morbidity and mortality. We compared cardiovascular death rates in kidney transplant recipients to the general population and identified risk…
  • 2019 American Transplant Congress

    Cardiac Risk Assessment in Kidney Transplant Candidates: Clinical Usefulness of Different Guidelines

    A. Velioglu1, S. Mehdiyev1, H. Arikan1, E. Asicioglu1, A. Cincin2, S. Tuglular1

    1Nephrology, Marmara University School of Medicine, Istanbul, Turkey, 2Cardiology, Marmara University School of Medicine, Istanbul, Turkey

    *Purpose: Despite cardiovascular (CV) assessment recommended all kidney transplant recipients to minimize perioperative risk, the utility and reliability of various assessments are not well established.…
  • 2019 American Transplant Congress

    Advanced Immunological T-cell Ageing Defined by a Very Low Thymic Function Identifies Patients with a Substantial Increased Risk for Long-Term Mortality after Kidney Transplantation

    M. G. Betjes, A. Langerak, M. Klepper, N. Litjens

    Nephrology & Transplantation, Erasmus MC, Rotterdam, Netherlands

    *Purpose: End-stage renal disease is associated with premature ageing of the T-cell immune system. At the time of kidney transplantation the average biological age of…
  • 2019 American Transplant Congress

    Intracerebral Hemorrhage in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis

    W. Cheungpasitporn1, C. Thongprayoon2, P. Ungprasert3, K. Wijarnpreecha4, F. T. Chebib2, P. T. Kroner4

    1Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, 2Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, 3Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 4Department of Medicine, Mayo Clinic, Jacksonville, FL

    *Purpose: This study aimed to evaluate the hospitalization rate for intracerebral hemorrhage (ICH) among renal transplant patients with adult polycystic kidney disease (ADPKD) and its…
  • 2019 American Transplant Congress

    Identification Of Pre-transplant Biomarkers Of Recipient Immune Dysfunction That Predict Recipient Risk Of Death Following Liver Transplant: The Immune Frailty Index

    K. E. Lunsford1, N. Aware1, K. Cleveland1, C. J. Manner1, D. T. Nguyen2, E. A. Graviss2, J. V. Thomas1, H. Vyas1, L. W. Moore1, S. A. Dorman1, A. Saharia1, C. M. Mobley1, M. J. Hobeika1, X. C. Li1, R. M. Ghobrial1

    1Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston Methodist Hospital, Houston, TX, 2Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX

    *Purpose: Cirrhosis-related immune dysfunction is well recognized and likely contributes to early mortality following liver transplant (LT) resulting from infections; however, few prior studies have…
  • 2019 American Transplant Congress

    Dialysis Lowers Pulmonary Embolism Mortality Risk in Kidney Transplantation

    B. Javaid, A. Gilbert, G. Vranic, J. Moore, B. Thomas, P. Abrams, S. Ghasemian, J. Verbesey, S. Yi, M. Cooper

    MedStar Georgetown Transplant Institute, Georgetown University School of Medicine, Washington, DC

    *Purpose: The primary purpose of this study was to assess the risk of mortality attributed to pulmonary embolism in kidney transplant recipients. We also wanted…
  • 2019 American Transplant Congress

    The Benefit of Kidney Transplantation over the Waitlist Depends on the Patient’s Comorbidities

    A. Andrade Izquierdo1, J. V. Reusing Jr1, V. Onusic1, F. Agena1, F. C. Lemos1, F. de Paula1, F. Gerab2, E. David-Neto1

    1Renal Transplantation Service, Hospital das Clínicas - University of São Paulo School of Medicine, Sao Paulo, Brazil, 2Department of Mathematics, FEI University, Sao Paulo, Brazil

    *Purpose: This study aimed to determine the impact of different comorbidities to the survival benefit of Kidney Transplantation (KTx) compared to waitlisted (WL) patients in…
  • 2019 American Transplant Congress

    Impact of Revised Policy for Hepatocellular Carcinoma MELD Exception Points on Recurrence after Liver Transplantation

    P. Le1, L. McClelland1, K. Knapp1, T. Xu1, S. Pelletier2

    1University of Virginia, Charlottesville, VA, 2Surgery, University of Virginia, Charlottesville, VA

    *Purpose: On October 8, 2015, a revised liver policy regarding HCC exception scores was implemented with the intention to create a better balance in transplant…
  • 2019 American Transplant Congress

    Elevated Visceral Adiposity is Associated with Post-Liver Transplant Mortality and Poorly Correlates with BMI in a Prospective Cohort Study

    R. Sharma, R. Rosenblatt, R. Knotts, J. Pisa, E. Verna

    Division of Liver Diseases and Transplantation, Columbia Univerisity Medical Center, New York, NY

    *Purpose: Obesity is increasingly common in end-stage-liver disease (ESLD). While obesity adversely affects outcomes, whether abnormalities in specific adipose tissue (AT) compartments lead to increased…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 32
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences